Following Wegovys addition of the CV risk indication, payer approval rates in Medicare Part D increased from 12% to 20% over the course of one year
My GLP-1 experience Most GLP-1 users arent eating the right foods, causing muscle loss and hormone dysfunction
15 Research, along with anecdotal observation, suggests providers may already be prescribing GLP-1 agonists other than liraglutide off-label for weight-loss in their non-diabetic patients
Int J Environ Res Public Health 16(15):2720 Vella A, Bock G, Giesler PD, Burton DB, Serra DB, Saylan M, Camilleri LM (2008) The effect of dipeptidyl peptidase-4 inhibition on gastric volume, satiation and enteroendocrine secretion in type 2 diabetes: a double-blind, placebo-controlled crossover study
Due to environmental factors, diet, age, stress, and others, we may end up with chronic inflammation